YAP 1 AS A NEW THERAPEUTIC TARGET IN NEUROFIBROMATOSIS TYPE 2

$690,666FY2010Department of DefenseDOD

Children'S Hospital Corporation, The

Investigators

View source on USAspending →

YAP 1 AS A NEW THERAPEUTIC TARGET IN NEUROFIBROMATOSIS TYPE 2 · GrantIndex